A strong signal of multiple safety problems with Chantix (varenicline), a drug to help people stop smoking, has been seen in a pilot program to identify new drug risks in adverse drug events reported to the U.S. Food and Drug Administration.
Get the full story...
In a move to bolster its cancer treatment drug supply Pfizer said that it has reached a deal with Serenex to buy the pharmaceutical drug company.
Get the full story...
Pfizer, which is the pharmaceutical company behind the drug Viagra is set to cut 420 jobs as it ends manufacturing operation in Kent, United Kingdom.
Get the full story...
Pfizer Reconfirms Full-Year 2007 and 2008 Financial Guidance and Updates Progress on Immediate Business Priorities
Get the full story...
Pfizer Also Announces Resignation of Chief Financial Officer Alan Levin, Who Will Continue as CFO Until Successor is Named
Get the full story...
"Worldwide pharmaceutical 2006 revenues met our expectations," said Ian Read, President of Worldwide Pharmaceutical Operations at Pfizer. "We focused on the top-line growth of key in-line medicines, including Lipitor, Celebrex, Lyrica, and Geodon, and we launched Sutent, Eraxis, Chantix, and Exubera in the U.S."
Read the full story
Full-Year 2006 Pfizer Revenues Grew 2 Percent to $48.4 Billion, Key Products Substantially Attained Targets, Nine Exceeded $1 Billion in Sales
Read the full story
